Cargando…
WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma
Stomach adenocarcinoma (STAD) is a malignant tumor with high histological heterogeneity. However, the potential mechanism of STAD tumorigenesis remains to be elucidated. The purpose of our research was to identify candidate genes associated with the diagnosis, progression, prognosis, and immunothera...
Autores principales: | Yuan, Qihang, Zhou, Qi, Ren, Jie, Wang, Guan, Yin, Chunlai, Shang, Dong, Xia, Shilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209604/ https://www.ncbi.nlm.nih.gov/pubmed/33982398 http://dx.doi.org/10.1002/cam4.3946 |
Ejemplares similares
-
Identification of Early Diagnostic and Prognostic Biomarkers via WGCNA in Stomach Adenocarcinoma
por: Tan, Ruoyue, et al.
Publicado: (2021) -
Bioinformatics analysis of the prognostic and immunotherapeutic significance of NPRL2 in stomach adenocarcinoma
por: Pi, Yilin, et al.
Publicado: (2022) -
LINC02126 is a potential diagnostic, prognostic and immunotherapeutic target for lung adenocarcinoma
por: Wang, Junbin, et al.
Publicado: (2022) -
Multi-omics profiling and digital image analysis reveal the potential prognostic and immunotherapeutic properties of CD93 in stomach adenocarcinoma
por: Wu, Baokang, et al.
Publicado: (2023) -
IRF7 is a Prognostic Biomarker and Associated with Immune Infiltration in Stomach Adenocarcinoma
por: Guo, Lili, et al.
Publicado: (2021)